• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Up 0.13%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    129.63 Up 0.46(0.36%) Aug 26, 4:00PM EDT
    |After Hours : 129.63 0.00 (0.00%) Aug 26, 5:05PM EDT
    Prev Close:129.17
    Open:130.00
    Bid:122.00 x 100
    Ask:133.69 x 100
    1y Target Est:171.75
    Beta:1.2842
    Earnings Date:Oct 27 - Oct 31 (Est.)
    Day's Range:128.26 - 131.60
    52wk Range:110.56 - 193.45
    Volume:1,057,808
    Avg Vol (3m):1,988,420
    Market Cap:29.07B
    P/E (ttm):325.70
    EPS (ttm):0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.36%29.07B
    AMGNUp 1.02%128.70B
    BAXUp 0.17%25.66B

    Key Statistics

    Forward P/E (1 yr):21.68
    P/S (ttm):10.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :4.65
    Quarterly EPS Est (Sep-16) :1.19
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.52

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback